Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.
about
Mode of administration of dulaglutide: implications for treatment adherenceAdvances in the treatment of type 2 diabetes: impact of dulaglutideSGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectivesA novel, long-acting glucagon-like peptide receptor-agonist: dulaglutideAdverse Effects of GLP-1 Receptor AgonistsThe New Era of Drug Therapy for Obesity: The Evidence and the ExpectationsPharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular eventsOnce-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study.A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy.Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance.Mechanisms for the cardiovascular effects of glucagon-like peptide-1.Dulaglutide: A Review in Type 2 Diabetes.Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy.Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.Incretin-Based Therapy for Diabetes: What a Cardiologist Needs to Know.Dulaglutide in the treatment of adult type 2 diabetes: a perspective for primary care providers.Cardiovascular safety and benefits of GLP-1 receptor agonists.Gastrointestinal-Renal Axis: Role in the Regulation of Blood PressureEffects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide.The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.Cardiovascular outcome studies with glucagon-like peptide 1 receptor agonists-what will REWIND add?The effect of liraglutide on renal function: A randomized clinical trial.Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.
P2860
Q26744065-9E08F3F7-AB09-4AEF-A459-BAD2EB7A85A5Q26746220-2CCB5481-A2B4-447A-A1CB-FD822707F6B3Q26746901-F229347E-0424-475C-A372-521963AEF237Q26796417-FAD43E45-70C8-43F2-8BA8-9ABA3E5ABF65Q26801346-762F7B3F-6B25-4EEF-8990-75B1D0B55C3FQ26827555-95FF9866-B36B-4AD7-B2FD-3F3AE1F182BAQ30249371-B73B7D6B-A7ED-48F4-B197-E7627CF91BDCQ31082841-2FF90635-231E-428C-9A13-B2D4780244A7Q33815573-23F13C49-C170-487A-B995-F3110B66F6F8Q35784245-CCD52DB1-E582-4A25-B141-BF4F2B52BA10Q36611527-7848332A-BC66-4FE4-A21C-DDEC4846D982Q37340216-D4916A9A-16C1-4398-836D-CCCDEC1365F8Q37345660-95EC7EB4-F422-4043-8AAD-A9A1ECE2C720Q37402786-A2DE0DB2-96EE-4A1E-B730-F00FD3F19161Q37586881-D6A50D1F-7808-4872-A691-B515F1EDF77CQ38309859-F5720A77-66DA-4AE4-9BA3-6649057398BEQ38358921-AD1AC2DF-EF6E-449A-9282-2113AE07DA5BQ38542098-622C3C82-0DA8-4ABC-BCF6-680E24FFA31BQ38589032-D99DBA94-A206-47E3-993D-0A4FC60F44BCQ38595931-0B8BD57E-5439-46A2-BA65-E858D1168053Q38597109-EFF53EC5-548E-4B95-AFA8-0A4516EDCFF6Q38634679-A493F117-CE72-4676-AEB3-AC183AB32B53Q38776029-0A88E504-CC84-4B8B-BFA5-99DF21647E21Q38787756-B856EB02-1FAA-4E87-91BE-2BE88DAD2310Q38917672-055AD6EB-AA47-4FDB-9F59-B9CC63486CFDQ39013056-DD7214A1-B42E-42BE-9D75-34D4D0907890Q39164330-CC281C38-7598-4149-8C1B-E565AFE531BEQ39375164-0A301892-120E-4262-8497-842D6655B745Q39870068-7C75D859-46CB-4151-A82B-0D4F85437308Q40113914-B57EEAF8-0483-42C3-8448-EEB95BF12DDCQ40928685-94324EAC-6325-4A9C-A857-433609B00099Q46906226-4B0D9214-2847-497C-889B-D282F1AC15B4Q47119011-16910BCA-7283-4635-A55D-F414E980D396Q51381510-9B05076F-DDAE-4919-A1E6-ABB3078D05C1Q55345557-0BBDA933-2FED-4A5B-A4B7-BEADAE252B45
P2860
Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@en
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@nl
type
label
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@en
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@nl
prefLabel
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@en
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@nl
P2093
P1433
P1476
Effects of the once-weekly glu ...... with type 2 diabetes mellitus.
@en
P2093
David A Calhoun
Eva M Lonn
Honghua H Jiang
Keith C Ferdinand
Kenneth E Robertson
Mary Jane Geiger
Philip T Sager
Rebecca J Threlkeld
Rocco Brunelle
William B White
P304
P356
10.1161/HYPERTENSIONAHA.114.03062
P407
P577
2014-06-30T00:00:00Z